Posted on 07 APRIL 2015 – vivoPharm Pty Ltd (“vivoPharm”) announced today that it has entered into an agreement with Protea Biosciences Group, Inc. (OTCQB: PRGB) (“Protea”) for the purchase of vivoPharm Pty Ltd and all of its subsidiaries. Protea is
Posted on 10 MAY 2013: John Lambrick is the General Counsel of RMIT University, based in Melbourne, Australia. The role involves the provision of a wide range of legal services to the university. Being a technology-orientated university, John’s practice has a heavy emphasis
Posted on 11 APRIL 2012: RMIT University and vivoPharm today jointly announced the sale of RMIT Drug Discovery Technologies Pty Ltd (RDDT) to vivoPharm Pty Ltd. As a result of the share based transaction RMIT will become a 20% shareholder in vivoPharm.RDDT is
Posted on 18 JANUARY 2012: vivoPharm Pty Ltd has entered into a partner- ship with Experimental Pharmacology & Oncology Berlin-Buch GmbH (EPO), one of Germanys -leading preclinical oncology testing company. Read More
Posted on 26 SEP 2011: Adelaide, South Australia (September 26, 2011) – vivoPharm Pty Ltd is pleased to announce that Ian Nisbet, PhD, MAICD has joined its Board of Directors and has been appointed as the new Chairman of the Board.
Posted on 13 SEP 2011: Hershey, PA. Sept. 13. An official ribbon cutting ceremony marked the opening of vivoPharm’s new American facility, signifying a time of promising growth and new beginnings for the Australian-based contract research organization (CRO). For nearly a decade,